| Variation name (cDNA level) | Variation name (protein level) | Variation status | Variation class |
| c.3940C>T | p.Arg1314X | Hemizygous | Mutation |
| wt codon | wt aa | mutant codon | mutant aa | mutational event | mutation type |
| CGA | Arg | TGA | Stop | C->T | Ts |
| Structure | Key Residue (HCD) | Pyrimidin doublet | CpG |
| CRD-repeat #9 | No | Yes |
| At the mRNA level | On restriction map |
| r.[3940c>u, 3922_4071del,3787_4071del] | New restriction site(s): Mae III Lost restriction site(s): none |
| On isoforms (a blue cell indicates that the corresponding isoform is affected by the mutation) | ||||||
| Dp 427c | Dp 427m | Dp 427p | Dp 260 | Dp 140 | Dp 116 | Dp 71 |
| Immunofluorescence | ||||||
| dys 1 | dys 2 | dys 3 | ||||
| No signal | Irregular Medium | Irregular Low | ||||
| Western Blot | ||
| dys 1 | dys 2 | dys 3 |
| No signal | No signal |
| Sample ID | Patient status | Gender | Transmission | Age of onset | Age of death | Geographic origin |
| ---346-8-71 | Proband | Male | Familial | FRANCE |
| Phenotypic group |
| BMD |
| Reference ID | Reference |
| 106 | Unpublished data |